ArticleEuropean radiology2025
Respiratory symptoms associated with a new lobe-based bronchial scoring system in an urban Chinese low-dose CT screening population.
Article in European radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectiveTo develop a lobe-based bronchial scoring system in a general Chinese urban population undergoing low-dose CT (LDCT) screening and examining the association between the scores and the presence and absence of respiratory symptoms. MATERIALS AND
methodsA total of 989 Chinese participants aged 40-74 from the NELCIN-B3 study underwent LDCT screening. The scoring system assessed bronchiectasis by summing up CT findings in each of the five lung lobes, including severity and extent of bronchial dilatation and airway wall thickness, as well as the presence of mucoid impaction. The modified Reiff score was used as comparison. Multivariable logistic regression analyses were performed to examine the relationship between bronchial scores and respiratory symptoms.
resultsThe study included 44.8% men with a median age of 62 years. Among 416 participants with bronchiectasis, mild bronchial dilatation and airway wall thickening of one generation were most common in the right lower lobe (20.7% and 15.2%, respectively). The percentage of lung lobes with bronchiectasis aligned with the modified Reiff score, showing high percentages in the right lower lobe of moderate score and of high score (92% and 90%, respectively). Multivariable analysis showed that high score was associated with wheeze (OR: 2.35; 95% CI: 1.16-4.75), especially in the upper lung region (OR: 2.25; 95% CI: 1.04-4.88), and with a lower likelihood of chest pain (OR: 0.49; 95% CI: 0.28-0.88).
conclusionIn a general Chinese urban population, over 40% of participants had bronchiectasis, mostly in the lower lung regions. Higher bronchial scores were positively associated with wheeze and negatively associated with chest pain. KEY POINTS: Question Bronchiectasis is frequently detected on low-dose CT lung cancer screening. However, a lob-based bronchial scoring, its clinical relevance and association with respiratory symptoms are lacking. Findings Over 40% of participants had bronchiectasis, mostly in the lower lobes. Higher bronchial scores were associated with increased wheeze risk and reduced chest pain. Clinical relevance Early detection of bronchiectasis through CT-based scoring in lung cancer screening can improve assessment of respiratory health, enabling timely interventions and potentially reducing disease progression. Future research should explore the clinical implications of our new bronchial scoring system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.